Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Talking Therapeutics

Douglass Jennings
Talking Therapeutics
Are all SGLT2 Inhibitors Created Equal?
07/19/2024
In this installment of Talking Therapeutics, Dr Jennings explores a new study that evaluates dapagliflozin against empagliflozin in patients with heart failure.
In this installment of Talking Therapeutics, Dr Jennings explores a new study that evaluates dapagliflozin against empagliflozin in patients with heart failure.
In this installment of Talking...
07/19/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Clearing Up Lingering Racial Bias in Medicine
06/24/2024
In this installment of Talking Therapeutics, Dr Jennings reviews a study demonstrating that racial bias in medicine may prevent positive treatment outcomes for Black patients with hypertension and heart failure with a reduced ejection...
In this installment of Talking Therapeutics, Dr Jennings reviews a study demonstrating that racial bias in medicine may prevent positive treatment outcomes for Black patients with hypertension and heart failure with a reduced ejection...
In this installment of Talking...
06/24/2024
Pharmacy Learning Network
Douglas Jennings
Talking Therapeutics
Another Win for GLP-1 Receptor Agonists: Treatment for Patients With Diabetes and CKD
06/06/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week's installment of Talking Therapeutics, Dr Jennings explores a new trial that evaluates the impact of GLP-1 agonists on kidney and cardiovascular endpoints in patients with diabetes and chronic kidney disease.
In this week's installment of Talking Therapeutics, Dr Jennings explores a new trial that evaluates the impact of GLP-1 agonists on kidney and cardiovascular endpoints in patients with diabetes and chronic kidney disease.
In this week's installment of...
06/06/2024
Pharmacy Learning Network
Douglas Jennings
Talking Therapeutics
A Striking Win for Statins
05/24/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings explores a new paper outlining the potential benefit of statins on key outcomes in patients with heart failure with preserved ejection fraction (HFpEF).
In this installment of Talking Therapeutics, Dr Jennings explores a new paper outlining the potential benefit of statins on key outcomes in patients with heart failure with preserved ejection fraction (HFpEF).
In this installment of Talking...
05/24/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Another Dangerous DOAC Drug Interaction
05/09/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings explores another potentially dangerous direct-acting oral anticoagulant (DOAC) combination based on a recent study.
In this installment of Talking Therapeutics, Dr Jennings explores another potentially dangerous direct-acting oral anticoagulant (DOAC) combination based on a recent study.
In this installment of Talking...
05/09/2024
Pharmacy Learning Network
Talking Therapeutics
Advancing Decongestive Strategies in Acute Heart Failure
04/25/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings analyzes recent study findings determining efficacy of dapagliflozin in patients with acute heart failure.
In this installment of Talking Therapeutics, Dr Jennings analyzes recent study findings determining efficacy of dapagliflozin in patients with acute heart failure.
In this installment of Talking...
04/25/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Strong Evidence for Harm When Combining SSRIs and Blood Thinners
04/09/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings discusses the risks associated with combining selective serotonin inhibitors (SSRIs) and blood thinners.
In this installment of Talking Therapeutics, Dr Jennings discusses the risks associated with combining selective serotonin inhibitors (SSRIs) and blood thinners.
In this installment of Talking...
04/09/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Contraindications Associated With Combining Amiodarone and Rivaroxaban
04/08/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings examines the interactions between amiodarone and rivaroxaban for patients under prescription, outlining crucial considerations for prescribers when administering these medications to...
In this installment of Talking Therapeutics, Dr Jennings examines the interactions between amiodarone and rivaroxaban for patients under prescription, outlining crucial considerations for prescribers when administering these medications to...
In this installment of Talking...
04/08/2024
Pharmacy Learning Network
Douglass Jennings
Talking Therapeutics
A New Standard for Calcium Replacement in Pregnancy
03/14/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings explores a new study that evaluated a simplified calcium administration plan to prevent hypertensive-related pregnancy complications.
In this installment of Talking Therapeutics, Dr Jennings explores a new study that evaluated a simplified calcium administration plan to prevent hypertensive-related pregnancy complications.
In this installment of Talking...
03/14/2024
Pharmacy Learning Network
Douglass Jennings
Talking Therapeutics
Confirmed Risks for MI and CVA With Triptan Therapy
03/12/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings reviews triptans and their impact on myocardial infarction and cerebrovascular accidents.
In this installment of Talking Therapeutics, Dr Jennings reviews triptans and their impact on myocardial infarction and cerebrovascular accidents.
In this installment of Talking...
03/12/2024
Pharmacy Learning Network

Meet the Author

Dr Jennings is currently an Associate Professor of Pharmacy at Long Island University and the clinical pharmacist for the Heart Transplant and LVAD teams at New York- Presbyterian Hospital Columbia University Irving Medical Center.
He is an active researcher in his field, and he has published over 120 peer-reviewed abstracts and manuscripts, primarily focusing on the pharmacotherapy of patients under mechanical circulatory support.
As a recognized expert in this area, he has been invited to speak at numerous national and international venues, including meetings in France, Saudia Arabia, and India.
Finally, Dr Jennings has been active in professional organizations throughout his career. He is a fellow of the American College of Clinical Pharmacy, the American College of Cardiology, the Heart Failure Society of America, and the AHA.

Advertisement

Additional Insights

Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
Videos
Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
11/10/2020
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director,...
11/10/2020
Pharmacy Learning Network
Exploring Prescribing Rates of Combination Therapy for BP Control
Videos
Exploring Prescribing Rates of Combination Therapy for BP Control
07/08/2020
Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control.
Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control.
Julie Johnson, PharmD, and...
07/08/2020
Pharmacy Learning Network
Association Between Blood Pressure Levels, Racial Disparities in Later-Life Cognitive Decline
Videos
Association Between Blood Pressure Levels, Racial Disparities in Later-Life Cognitive Decline
06/17/2020
Deborah Levine, MD, MPH, breaks down her recent study and explains why black individuals with a higher blood pressure level may be linked to racial disparities in cognitive decline.
Deborah Levine, MD, MPH, breaks down her recent study and explains why black individuals with a higher blood pressure level may be linked to racial disparities in cognitive decline.
Deborah Levine, MD, MPH, breaks...
06/17/2020
Pharmacy Learning Network
Is Warfarin Beneficial in Reducing Ischemic Stroke Incidence in Patients With AF, End-Stage Renal Disease?
Videos
Is Warfarin Beneficial in Reducing Ischemic Stroke Incidence in Patients With AF, End-Stage Renal Disease?
05/04/2020
Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...
Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...
Mandeep S Randhawa, MD, division...
05/04/2020
Pharmacy Learning Network
Videos
Acute Coronary Syndromes
06/25/2015
At a regional Pharmacy Learning Network meeting, Dr. Jean Nappi sat down with Dr. Randolph Fugit to discuss acute coronary syndromes.
At a regional Pharmacy Learning Network meeting, Dr. Jean Nappi sat down with Dr. Randolph Fugit to discuss acute coronary syndromes.
At a regional Pharmacy Learning...
06/25/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement